In light of the recent FDA hold on Juno's clinical trial following the death of two patients, I thought I would publish this bit of DD that I had been working on for a few months. It is incomplete, except for a discussion of cytokine storm, which seems to be Juno's - and other CART companies' - main hurdle.

*** L3 or above subscription required to read the rest of the article ... Login or Subscribe/Upgrade here